Artificial Intelligence Antios Therapeutics | Innovative Therapies for Viral Diseases


Enterprise, Biotechnology, Pharmaceuticals, Health Care, Therapeutics, Drug Discovery, Viral Diseases Atlanta, GA, United States

Antios Therapeutics

Artificial Intelligence


Antios Therapeutics | Innovative Therapies for Viral Diseases

Antios Therapeutics

Biotechnology, Pharmaceuticals, Health Care, Therapeutics, Drug Discovery, Viral Diseases


Atlanta, GA, United States

Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its lead oral drug candidate for potentially curative treatment of HBV infections.

Our lead therapeutic candidate, ATI-2173, is a first-in-class Active Site Polymerase Inhibitor Nucleotide (ASPIN) that is in clinical development as the backbone of an oral, once-daily potential curative therapy for Hepatitis B Virus. To date, we have completed extensive pre-clinical work, as well as Phase 1 studies in both healthy volunteers and HBV-infected individuals. Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.

 
 

   Total Funding: $125.4 M

   Funding Stage: Series B

   Business Stage: Scaling Up

   Market: B2B

   Company Size: 26 to 50

   Founded: 2018

 
 

Date

Round

$ Raised

Investors

04/12/2021

Series B

$96M

Soleus Capital, Sixty Degree Capital, RA Capital Management, Pontifax, Lumira Ventures, LifeSci Venture Partners, Granite Point Capital, Domain Associates, CAM Capital, Amzak Health Investors, Altium Capital, Aisling Capital, Adage Capital Management

Date : 04/12/2021

Round: Series B

$ Raised: $96M

Investors: Soleus Capital, Sixty Degree Capital, RA Capital Management, Pontifax, Lumira Ventures, LifeSci Venture Partners, Granite Point Capital, Domain Associates, CAM Capital, Amzak Health Investors, Altium Capital, Aisling Capital, Adage Capital Management

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Antios Therapeutics

 
 
 
Greg Mayes


Greg Mayes
President and CEO

Idean M.


Idean M.
Co-founder

Tamra Adams


Tamra Adams
Chief Financial Officer

Douglas Mayers


Douglas Mayers
Chief Medical Officer

 
 

Antios Therapeutics is growing. Want to work at Antios Therapeutics? Antios Therapeutics is hiring. Join team at Antios Therapeutics

 
 
appengine.ai

World's Most Promising AI/ML Startups